Erythropoietin – a novel concept for neuroprotection

Overview of attention for article published in European Archives of Psychiatry and Clinical Neuroscience, August 2001

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)

Mentioned by

patent: 9 patents

Citations

dimensions_citation: 127 Dimensions

Readers on

mendeley: 45 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 9 patents that reference this research output.

Methods for treating inflammatory disorders and traumatic brain injury using stabilized…

Grant US-11559565-B2

United States of America

Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators

Grant US-10047132-B2

United States of America

Methods for treating inflammatory disorders and traumatic brain injury using stabilized…

Grant US-10010583-B2

United States of America

Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators

Grant US-9765128-B2

United States of America

Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders

Grant US-9585932-B2

United States of America

Methods for treating inflammatory disorders and traumatic brain injury using stabilized…

Grant US-9345745-B2

United States of America

Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators

Grant US-8653028-B2

United States of America

Methods of Increasing Endogenous Erythropoietin (EPO)

Application EP-2324834-A3

European Patent Office

METHODS FOR REGULATING CO-STIMULATORY MOLECULE EXPRESSION WITH REACTIVE OXYGEN

Application WO-2003031643-A2

World Intellectual Property Organisation (WIPO)